Zai Lab (ZLAB) Change in Account Payables (2020 - 2026)
Zai Lab (ZLAB) posted quarterly Change in Account Payables of $4.3 million for Q1 2026, up 56.65% year-on-year from $2.7 million in Q1 2025, and down 79.06% on a QoQ basis from $20.4 million in Q4 2025.
Zai Lab (ZLAB) Change in Account Payables (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Change in Account Payables for 7 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables rose 56.65% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (up 54.65% YoY) and the FY2025 annual result came in at $19.9 million, up 1002.04% from the prior year.
- Change in Account Payables declined to $4.3 million in Q1 2026 per ZLAB's latest filing, from $20.4 million in the prior quarter.
- Over the last five years, Change in Account Payables for ZLAB reached as high as $46.3 million in Q4 2023 and fell as low as -$28.0 million in Q1 2022.
- A 5-year average of $294588.2 and a median of $2.7 million in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables tumbled 3988.69% — and 2025, when it surged 332.49%.
- Year by year, Change in Account Payables stood at -$24.9 million in 2022, then jumped by 285.76% to $46.3 million in 2023, then plunged by 118.91% to -$8.8 million in 2024, then jumped by 332.49% to $20.4 million in 2025, then slumped by 79.06% to $4.3 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $4.3 million, $20.4 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 20.35 Mn |
| Dec 31, 2025 | 20.35 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | -8.75 Mn |
| Dec 31, 2024 | -8.75 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Mar 31, 2024 | -13.37 Mn |
| Mar 31, 2024 | -13.37 Mn |
| Dec 31, 2023 | 46.30 Mn |
| Dec 31, 2023 | 46.30 Mn |